🇺🇸 Novavax COVID-19 Vaccine in United States

28 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Blood Pressure Decreased — 3 reports (10.71%)
  2. Cough — 3 reports (10.71%)
  3. Covid-19 — 3 reports (10.71%)
  4. Dyspnoea — 3 reports (10.71%)
  5. Nausea — 3 reports (10.71%)
  6. Peripheral Swelling — 3 reports (10.71%)
  7. Product Dose Omission Issue — 3 reports (10.71%)
  8. Weight Decreased — 3 reports (10.71%)
  9. Alopecia — 2 reports (7.14%)
  10. Contusion — 2 reports (7.14%)

Source database →

Other Immunology approved in United States

Frequently asked questions

Is Novavax COVID-19 Vaccine approved in United States?

Novavax COVID-19 Vaccine does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Novavax COVID-19 Vaccine in United States?

Novavax is the originator. The local marketing authorisation holder may differ — check the official source linked above.